Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder

@article{Roitman2014PreliminaryOP,
  title={Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder},
  author={P. Roitman and R. Mechoulam and R. Cooper-Kazaz and A. Shalev},
  journal={Clinical Drug Investigation},
  year={2014},
  volume={34},
  pages={587-591}
}
  • P. Roitman, R. Mechoulam, +1 author A. Shalev
  • Published 2014
  • Medicine
  • Clinical Drug Investigation
  • Background and ObjectivesMany patients with post-traumatic stress disorder (PTSD) achieve but partial remission with current treatments. [...] Key Method This open-label study evaluates the tolerance and safety of orally absorbable Δ9-tetrahydrocannabinol (THC) for chronic PTSD.MethodsTen outpatients with chronic PTSD, on stable medication, received 5 mg of Δ9-THC twice a day as add-on treatment.ResultsThere were mild adverse effects in three patients, none of which led to treatment discontinuation.Expand Abstract
    111 Citations
    Investigational drugs under development for the treatment of PTSD
    • 20
    Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
    • 16
    • Highly Influenced
    • PDF
    Reviewing the Potential of Psychedelics for the Treatment of PTSD
    • 6
    • PDF
    Cannabinoids as therapeutics for PTSD.
    • 6
    Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
    • 25

    References

    SHOWING 1-10 OF 28 REFERENCES
    The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
    • G. A. Fraser
    • Psychology, Medicine
    • CNS neuroscience & therapeutics
    • 2009
    • 184
    • PDF
    Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain
    • 11
    Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.
    • 87
    • Highly Influential
    • PDF
    PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
    • 88
    • PDF
    Effects of Smoked Cannabis and Oral δ9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy
    • 59
    • PDF
    Cannabis use among military veterans after residential treatment for posttraumatic stress disorder.
    • 63
    • PDF
    Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
    • 124
    • PDF
    Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse.
    • 488
    Elevated Brain Cannabinoid CB1 Receptor Availability in Posttraumatic Stress Disorder: A Positron Emission Tomography Study
    • 207
    • PDF
    A Controlled Study of Imagery Rehearsal for Chronic Nightmares in Sexual Assault Survivors With PTSD: A Preliminary Report
    • 200
    • Highly Influential
    • PDF